Medical Chief, Mood, Anxiety and Impulsivity Disorders Program, Douglas Institute
serge_dot_beaulieu_At_mcgill_dot_ca |
2006
Baptista T., Martinez J., Lacruz A., Rangel N., Beaulieu S., Serrano A., Arape Y., Martinez M., de Mendoza S., Teneud L., Hernandez L. (2006). Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial, Can J Psychiatry, 51(3), 192-6.
Yatham L. N., Kennedy S. H., O'Donovan C., Parikh S. V., MacQueen G., McIntyre R. S., Sharma V., Beaulieu S. (2006). Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007, Bipolar Disord, 8(6), 721-39.